Pacific Biosciences of California, Inc. (PACB) Financials
PACB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 751.9 million | 785.1 million |
| March 31, 2026 | 782.4 million | 780.0 million |
| Dec. 31, 2025 | 784.1 million | 778.7 million |
| Sept. 30, 2025 | 803.2 million | 767.1 million |
PACB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -84.9 million | 13.7 million |
| March 31, 2026 | -47.7 million | 4.5 million |
| Dec. 31, 2025 | -19.9 million | 9.6 million |
| Sept. 30, 2025 | -18.6 million | 11.0 million |
PACB Net Income
No data available :(
PACB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 236.9 million | 644.3 million | 61.8 million |
| March 31, 2026 | 276.0 million | 644.1 million | 59.0 million |
| Dec. 31, 2025 | 279.5 million | 702.4 million | 57.5 million |
| Sept. 30, 2025 | 298.7 million | 645.2 million | 54.9 million |
PACB Shares Outstanding
PACB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 4.6 million | 23.0 million | 33.4 million | - |
| March 31, 2026 | 3.0 million | 19.6 million | 31.2 million | - |
| Dec. 31, 2025 | 861000 | 22.9 million | 34.1 million | - |
| Sept. 30, 2025 | 86000 | 22.8 million | 31.1 million | - |
PACB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 39.0 million | 26.4 million |
| March 31, 2026 | 37.2 million | 24.3 million |
| Dec. 31, 2025 | 44.6 million | 27.9 million |
| Sept. 30, 2025 | 38.4 million | 23.4 million |
PACB Revenue by Segment
Graph available only for paid members. Upgrade to see it.
PACB
Price: $2.33
52 week price:
Earnings Per Share: -0.42 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 5.8 million
Ebitda: -20.1 millionMarket Capitalization: 838.6 million